Trump Administration Allows Compounding Pharmacies to Make Popular Peptides

Contains AI

NPR News reports on a major policy shift from the Department of Health and Human Services allowing small compounding pharmacies to manufacture six popular, unapproved peptide compounds. This episode explores the background of FDA regulations, compounding pharmacy practices, soaring consumer demand for metabolic and anti-aging therapies, and the ongoing debate among public health analysts regarding patient access, manufacturing capacity, and safety standards. #Peptides #CompoundingPharmacies #HealthPolicy #NPRNews

This episode includes AI-generated content.